Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.41 USD | -0.70% | -14.55% | -24.19% |
22/04 | Adial Pharmaceuticals Granted US Patent for Genetic Diagnostic, AD04 Combination to Treat Alcohol Use Disorder | MT |
12/04 | Top Premarket Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.19% | 57.17L | |
+33.37% | 5.08TCr | |
+1.55% | 4.28TCr | |
+49.17% | 4.2TCr | |
-4.22% | 2.95TCr | |
+11.57% | 2.61TCr | |
-21.00% | 1.91TCr | |
+7.36% | 1.31TCr | |
+28.30% | 1.22TCr | |
+23.80% | 1.21TCr |
- Stock Market
- Equities
- ADIL Stock
- News Adial Pharmaceuticals, Inc.
- Adial Pharmaceuticals Secures US Patent Allowance for AD04, Genetic Diagnostic Combination